Matches in SemOpenAlex for { <https://semopenalex.org/work/W3100606543> ?p ?o ?g. }
Showing items 1 to 80 of
80
with 100 items per page.
- W3100606543 abstract "Introduction: Left ventricular thrombus (LVT) is associated with a higher risk of ischemic stroke and peripheral embolization. Societal guidelines recommend the use of warfarin, with direct oral anticoagulants (DOACs) only for patients unable to tolerate warfarin. Data on natural history and thrombus resolution with anticoagulation (AC), especially with DOACs is scarce. We studied the natural history of LVT with AC with emphasis on comparing warfarin and DOACs use. Methods: This is a single center, retrospective study conducted in an academic medical center. We identified patients (echocardiogram, CT or MRI) with a confirmed LVT study who were followed at our center. Chart review was conducted to collect clinical information at presentation and on follow up. Type and duration of anticoagulation, INR levels and clinical outcomes (bleeding, ischemic stroke or peripheral embolization, mortality) were recorded. Thrombus resolution on follow up imaging was also recorded. Results: LVT was confirmed in a total of 110 patients. Mean age was 59±14 years. 79% were men. Underlying etiology was chronic ischemic cardiomyopathy in 58%, non-ischemic cardiomyopathy in 23%. AC was started in 96 (87%) patients (in remaining patients AC was thought to be contraindicated). Of those on long-term AC, 60 patients (63%) were treated with warfarin, 3 patients (3%) with enoxaparin and 32 patients (33%) with a DOACs. At one year follow up, 11 patients (10%) had a stroke while on any AC. Two of these patients had hemorrhagic stroke (both on warfarin) and 9 patients had ischemic stroke. Of those with ischemic stroke 7 were on warfarin and 2 patients on DOACs had ischemic strokes. Of those with ischemic stroke on warfarin, 71% had subtherapeutic INR. The 1-year risk of any stroke was 15% in warfarin group (12% risk of ischemic stroke) compared to 6% in the DOACs group (p= 0.33). Total of 55 (57%) of patient started on AC had resolution of thrombus. 37 (63%) patients on warfarin and 18 (53%) on DOACs had resolution of thrombus (p= 0.85). Conclusions: One year risk of stroke with LVT is high (10%) even with AC. Most patients with ischemic stroke on warfarin had subtherapeutic INR. There was no statistical difference in stroke risk or rate of thrombus resolution between warfarin and DOACs treated patients." @default.
- W3100606543 created "2020-11-23" @default.
- W3100606543 creator A5019420847 @default.
- W3100606543 creator A5024870451 @default.
- W3100606543 creator A5029006215 @default.
- W3100606543 creator A5039759417 @default.
- W3100606543 creator A5054257293 @default.
- W3100606543 creator A5057586381 @default.
- W3100606543 creator A5072253769 @default.
- W3100606543 creator A5081437624 @default.
- W3100606543 creator A5091249334 @default.
- W3100606543 date "2020-11-17" @default.
- W3100606543 modified "2023-10-16" @default.
- W3100606543 title "Abstract 15803: Effectiveness of Direct Oral Anticoagulant versus Warfarin in the Treatment of Left Ventricular Thrombus" @default.
- W3100606543 doi "https://doi.org/10.1161/circ.142.suppl_3.15803" @default.
- W3100606543 hasPublicationYear "2020" @default.
- W3100606543 type Work @default.
- W3100606543 sameAs 3100606543 @default.
- W3100606543 citedByCount "0" @default.
- W3100606543 crossrefType "journal-article" @default.
- W3100606543 hasAuthorship W3100606543A5019420847 @default.
- W3100606543 hasAuthorship W3100606543A5024870451 @default.
- W3100606543 hasAuthorship W3100606543A5029006215 @default.
- W3100606543 hasAuthorship W3100606543A5039759417 @default.
- W3100606543 hasAuthorship W3100606543A5054257293 @default.
- W3100606543 hasAuthorship W3100606543A5057586381 @default.
- W3100606543 hasAuthorship W3100606543A5072253769 @default.
- W3100606543 hasAuthorship W3100606543A5081437624 @default.
- W3100606543 hasAuthorship W3100606543A5091249334 @default.
- W3100606543 hasConcept C126322002 @default.
- W3100606543 hasConcept C127413603 @default.
- W3100606543 hasConcept C164705383 @default.
- W3100606543 hasConcept C2775932942 @default.
- W3100606543 hasConcept C2776301958 @default.
- W3100606543 hasConcept C2777650959 @default.
- W3100606543 hasConcept C2777693794 @default.
- W3100606543 hasConcept C2778198053 @default.
- W3100606543 hasConcept C2778205648 @default.
- W3100606543 hasConcept C2779161974 @default.
- W3100606543 hasConcept C2780073493 @default.
- W3100606543 hasConcept C2780645631 @default.
- W3100606543 hasConcept C2781362458 @default.
- W3100606543 hasConcept C71924100 @default.
- W3100606543 hasConcept C78085059 @default.
- W3100606543 hasConcept C78519656 @default.
- W3100606543 hasConceptScore W3100606543C126322002 @default.
- W3100606543 hasConceptScore W3100606543C127413603 @default.
- W3100606543 hasConceptScore W3100606543C164705383 @default.
- W3100606543 hasConceptScore W3100606543C2775932942 @default.
- W3100606543 hasConceptScore W3100606543C2776301958 @default.
- W3100606543 hasConceptScore W3100606543C2777650959 @default.
- W3100606543 hasConceptScore W3100606543C2777693794 @default.
- W3100606543 hasConceptScore W3100606543C2778198053 @default.
- W3100606543 hasConceptScore W3100606543C2778205648 @default.
- W3100606543 hasConceptScore W3100606543C2779161974 @default.
- W3100606543 hasConceptScore W3100606543C2780073493 @default.
- W3100606543 hasConceptScore W3100606543C2780645631 @default.
- W3100606543 hasConceptScore W3100606543C2781362458 @default.
- W3100606543 hasConceptScore W3100606543C71924100 @default.
- W3100606543 hasConceptScore W3100606543C78085059 @default.
- W3100606543 hasConceptScore W3100606543C78519656 @default.
- W3100606543 hasIssue "Suppl_3" @default.
- W3100606543 hasLocation W31006065431 @default.
- W3100606543 hasOpenAccess W3100606543 @default.
- W3100606543 hasPrimaryLocation W31006065431 @default.
- W3100606543 hasRelatedWork W1983415041 @default.
- W3100606543 hasRelatedWork W2056955110 @default.
- W3100606543 hasRelatedWork W2157689025 @default.
- W3100606543 hasRelatedWork W2278916550 @default.
- W3100606543 hasRelatedWork W2415605004 @default.
- W3100606543 hasRelatedWork W2883278003 @default.
- W3100606543 hasRelatedWork W3028955534 @default.
- W3100606543 hasRelatedWork W3100606543 @default.
- W3100606543 hasRelatedWork W3187266952 @default.
- W3100606543 hasRelatedWork W3193900294 @default.
- W3100606543 hasVolume "142" @default.
- W3100606543 isParatext "false" @default.
- W3100606543 isRetracted "false" @default.
- W3100606543 magId "3100606543" @default.
- W3100606543 workType "article" @default.